2020 | Validation of the Korean Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale
| JOURNAL OF CLINICAL NEUROLOGY |
2020 | Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein
| SCIENCE ADVANCES |
2020 | Impaired Functional Connectivity of Sensorimotor Network Predicts Recovery in Drug-Induced Parkinsonism | PARKINSONISM & RELATED DISORDERS |
2020 | Clinical and Striatal Dopamine Transporter Predictors of β-Amyloid in Dementia With Lewy Bodies | NEUROLOGY |
2020 | Changes in Plasma Arylsulfatase A Level as a Compensatory Biomarker of Early Parkinson's Disease
| SCIENTIFIC REPORTS |
2020 | Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns | NEUROBIOLOGY OF AGING |
2020 | Effects of Alzheimer's disease and Lewy body disease on subcortical atrophy | EUROPEAN JOURNAL OF NEUROLOGY |
2020 | Neural Correlates of Cognitive Performance in Alzheimer's Disease- and Lewy Bodies-Related Cognitive Impairment | JOURNAL OF ALZHEIMERS DISEASE |
2020 | A Case of Abnormal Postures in the Left Extremities after Pontine Hemorrhage: Dystonia or Pseudodystonia?
| JOURNAL OF MOVEMENT DISORDERS |
2020 | White matter hyperintensities and risk of levodopa-induced dyskinesia in Parkinson's disease
| ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY |
2020 | Subtypes of Sleep Disturbance in Parkinson's Disease Based on the Cross-Culturally Validated Korean Version of Parkinson's Disease Sleep Scale-2
| JOURNAL OF CLINICAL NEUROLOGY |
2019 | Cerebellar Connectivity in Parkinson's Disease With Levodopa-Induced Dyskinesia
| ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY |
2019 | The Influence of Body Mass Index at Diagnosis on Cognitive Decline in Parkinson's Disease
| JOURNAL OF CLINICAL NEUROLOGY |
2019 | Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone | BRAIN |
2019 | White Matter Hyperintensities as a Predictor of Freezing of Gait in Parkinson's Disease | PARKINSONISM & RELATED DISORDERS |
2019 | Frontal Atrophy as a Marker for Dementia Conversion in Parkinson's Disease With Mild Cognitive Impairment | HUMAN BRAIN MAPPING |
2019 | Detrimental Effect of Type 2 Diabetes Mellitus in a Large Case Series of Parkinson's Disease | PARKINSONISM & RELATED DISORDERS |
2019 | The Efficacy and Limits of Magnetic Resonance-Guided Focused Ultrasound Pallidotomy for Parkinson's Disease: A Phase I Clinical Trial | JOURNAL OF NEUROSURGERY |
2019 | Magnetic Resonance Imaging-Visible Perivascular Spaces in Basal Ganglia Predict Cognitive Decline in Parkinson's Disease | MOVEMENT DISORDERS |
2019 | Heterogeneous Patterns of Striatal Dopamine Loss in Patients with Young- versus Old-Onset Parkinson's Disease: Impact on Clinical Features
| JOURNAL OF MOVEMENT DISORDERS |
2019 | Enrichment of Exosome-Like Extracellular Vesicles from Plasma Suitable for Clinical Vesicular miRNA Biomarker Research
| JOURNAL OF CLINICAL MEDICINE |
2019 | Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus
| SCIENTIFIC REPORTS |
2019 | Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction | NEUROLOGY |
2019 | Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease | EUROPEAN JOURNAL OF NEUROLOGY |
2019 | Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson's disease
| Scientific Reports |
2019 | Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson's disease | Journal of Neurology |
2019 | Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies | European Journal of Nuclear Medicine and Molecular Imaging |
2019 | Mild cognitive impairment reverters have a favorable cognitive prognosis and cortical integrity in Parkinson's disease | NEUROBIOLOGY OF AGING |
2019 | Dysautonomia is associated with structural and functional alterations in Parkinson disease | NEUROLOGY |
2019 | Gastrectomy and nigrostriatal dopaminergic depletion in de novo Parkinson's disease | MOVEMENT DISORDERS |
2018 | The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2018 | Parkinson's disease-related non-motor features as risk factors for post-operative delirium in spinal surgery
| PLOS ONE |
2018 | Amyloid-β-related and unrelated cortical thinning in dementia with Lewy bodies. | NEUROBIOLOGY OF AGING |
2018 | A Novel Heterozygous ANO3 Mutation with Basal Ganglia Dysfunction in a Patient with Adult-Onset Isolated Segmental Dystonia.
| JOURNAL OF CLINICAL NEUROLOGY |
2018 | The Pattern of Striatal Dopamine Depletion as a Prognostic Marker in De Novo Parkinson Disease | CLINICAL NUCLEAR MEDICINE |
2018 | Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson's Disease? | CNS DRUGS |
2018 | Olfactory dysfunction in Alzheimer's disease- and Lewy body-related cognitive impairment | ALZHEIMERS & DEMENTIA |
2018 | The presence of depression in de novo Parkinson's disease reflects poor motor compensation
| PLOS ONE |
2018 | Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2018 | Putaminal dopamine depletion in de novo Parkinson’s disease predicts future development of wearing-off | PARKINSONISM & RELATED DISORDERS |
2018 | Gender-specific effect of uric acid on resting-state functional networks in de novo Parkinson's disease | PARKINSONISM & RELATED DISORDERS |
2018 | Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease | PARKINSONISM & RELATED DISORDERS |
2018 | The cholinergic contribution to the resting-state functional network in non-demented Parkinson's disease
| SCIENTIFIC REPORTS |
2018 | Subjective Cognitive Complaints and Objective Cognitive Impairment in Parkinson's Disease
| JOURNAL OF CLINICAL NEUROLOGY |
2018 | Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2018 | Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction | JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY |
2018 | Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease | JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY |
2017 | Levodopa dose maintenance or reduction in patients with Parkinson's disease transitioning to levodopa/carbidopa/entacapone | NEUROLOGY INDIA |
2017 | Early-onset mild cognitive impairment in Parkinson's disease: Altered corticopetal cholinergic network
| SCIENTIFIC REPORTS |
2017 | Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype? | EUROPEAN JOURNAL OF NEUROLOGY |